肺癌筛查中头颈癌的发病率:一项随机对照试验的二次分析
该研究为美国国家肺癌筛查试验的二次分析,比较高危吸烟者接受低剂量计算机断层扫描(LDCT)与胸部X线(CXR)筛查后头颈癌(HNC)的发病率。共纳入53452名参与者,中位随访6.2年。LDCT组HNC发病率为111.8例/10万人年,CXR组为87.1例/10万人年(率比1.30,95%CI 1.05-1.61);HNC死亡风险无显著差异(HR 0.80,95%CI 0.42-1.52)。
要点
- LDCT组头颈癌发病率略高于CXR组(率比1.30,95%CI 1.05-1.61)。
- 两组头颈癌死亡风险无显著差异(HR 0.80,95%CI 0.42-1.52)。
- 随着肺癌筛查指南的采纳和依从性提高,临床医生应认识到筛查中的偶发发现可能导致头颈癌检出增加。
核心结论
- 接受LDCT筛查的参与者头颈癌发病率略高;随着肺癌筛查指南的采纳和依从性提高,临床医生应认识到筛查中的偶发发现可能导致头颈癌检出增加。
研究设计与样本
- 美国国家肺癌筛查试验的二次分析,随机对照试验,比较LDCT与CXR筛查在高危个体(30包年吸烟者,目前吸烟或过去15年内戒烟,年龄55-74岁)中头颈癌的发病率。
- 共纳入53452名参与者,随机分组后中位随访6.2年。
主要发现
- LDCT组头颈癌发病率为111.8例/10万人年,CXR组为87.1例/10万人年(率比1.30,95%CI 1.05-1.61)。
- LDCT组头颈癌死亡率为11.7例/10万人年,CXR组为12.9例/10万人年(HR 0.80,95%CI 0.42-1.52)。
关键数值与推荐
- 黏膜头颈癌(口腔、口咽、喉、下咽、鼻腔/鼻窦或鼻咽)与非黏膜头颈癌(甲状腺或唾液腺)的亚组分析结果未在摘要中报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate the incidence of head and neck cancers (HNC) in high-risk current and/or former smokers with screening low-dose computed tomography (LDCT) chest versus chest x-ray (CXR). STUDY DESIGN: Second analysis of randomized clinical trial. METHODS: We performed a secondary analysis examining the incidence of HNC in the National Lung Screening Trial. This was a randomized trial comparing LDCT versus CXR screening for lung cancer detection in high-risk individuals (30 pack-year smokers who currently smoke or quit within the last 15 years, aged 55-74). We compared the incidence of HNC in participants screened with LDCT versus CXR. We performed subgroup analyses in participants with mucosal HNC (oral cavity, oropharynx, larynx, hypopharynx, nasal/sinus cavity, or nasopharynx) or nonmucosal HNC (thyroid or salivary gland) and examined survival in the two screening arms. RESULTS: This trial enrolled 53,452 participants with a median follow-up of 6.2 years after randomization. The incidence of HNC was 111.8 cases per 100,000 person-years in the LDCT group versus 87.1 cases per 100,000 person-years in the CXR group (rate ratio 1.30, 95% confidence interval [CI] 1.05-1.61). There were 11.7 deaths from HNC per 100,000 person-years in the LDCT group and 12.9 deaths per 100,000 person-years in the CXR group (hazard ratio 0.80, 95% CI 0.42-1.52). CONCLUSIONS: Participants screened with LDCT had a modestly higher incidence of HNC. As uptake and adherence of lung cancer screening guidelines improve, clinicians should recognize that incidental findings from screening may lead to increased detection of HNC. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:1609-1614, 2022.
引用
- Jassal JS, Grauer JS, Cramer JD, et al. Incidence of Head and Neck Cancer With Lung Cancer Screening: Secondary Analysis of a Randomized Controlled Trial. Laryngoscope. 2022. PMID: 34984679. doi:10.1002/lary.30006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。